Navigation Links
Video: New Research Discovers Independent Brain Networks Control Human Walking
Date:8/19/2007

aboratory provide a glimpse into the rehabilitative potential made possible through the pairing of our talented researchers and cutting-edge technologies."

Past studies by Bastian and her colleagues have found that certain types of brain damage interfere with walking ability, while others do not. For example, individuals with damage to the cerebral hemispheres can adapt while those with damage to the cerebellum are rarely able to.

This body of work sheds light on the specificity of walking adaptations and demonstrates that patients with certain types of brain damage can store a new walking pattern in the short term. Based on these findings, Bastian's goal is to learn how to make that pattern last for an extended period. Currently, Bastian is planning a study of stroke victims in order to test the long-term benefits of split-belt treadmill therapy. She is also studying children with more extreme forms of brain damage, including those that undergo a hemispherectomy, a neurosurgical procedure to treat seizures in which an entire half of the brain is removed. The initial findings are quite promising, showing that these children can adapt in the short term and improve their walking patterns. These and other similar studies are leading researchers down the path to more targeted, rational therapies for patients with brain injuries.

About the Kennedy Krieger Institute

Internationally recognized for improving the lives of children and adolescents with disorders and injuries of the brain and spinal cord, the Kennedy Krieger Institute in Baltimore, MD serves more than 13,000 individuals each year through inpatient and outpatient clinics, home and community services and school-based programs. Kennedy Krieger provides a wide range of services for children with developmental concerns mild to severe, and is home to a team of investigators who are contributing to the understanding of how disorders develop while pioneering new interventions and earlier diagno
'/>"/>

SOURCE Kennedy Krieger Institute

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Apollos human proteins boost stem cell research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ongoing Phase Ib trial demonstrated a 2.5 log10 me...nference Call Today at 8:30AM EST , , SAN DIEG...euticals, Inc. (Nasdaq: ANDS ) today announced r...b clinical trial of ANA598, the Company,s investig...98 was very well-tolerated and demonstrated potent...
(Date:1/7/2009)...sed On Osteotech,s Proprietary Human Collagen Tech...iling Anticipated in Third Quarter 2009 , , EA...Osteotech, Inc. (Nasdaq: OSTE ), a leader in the...ive healing, announced today that it has initiated...Regeneration Matrix. The first five patients in th...
(Date:1/6/2009)...cent controlled studies conducted by Dr. Richard B...that the patented ingredient in Glyc,n Go(TM), Gly... to increase levels of nitric oxide (NO) in the bo... in human subjects. , , Nitric oxide acts as a ...to the skeletal muscles. This is significant to 1...
(Date:1/6/2009)...rstCall/ -- , - Early Renewal of the Agreem...11 , - Expansion of the Scope of the Collab...ology , - Revised Commercial Terms and Paym...d Party , ExonHit Therapeutics (Alternext...xisting drug discovery collaboration with Allergan...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 610 1NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 610 2NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 610 3The New England Journal of Medicine Publishes EURIDIS ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrill 607 1The New England Journal of Medicine Publishes EURIDIS ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrill 607 2The New England Journal of Medicine Publishes EURIDIS ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrill 607 3The New England Journal of Medicine Publishes EURIDIS ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrill 607 4The New England Journal of Medicine Publishes EURIDIS ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrill 607 5ThermoGenesis Corp to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12 2007 392 1ThermoGenesis Corp to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12 2007 392 2ThermoGenesis Corp to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12 2007 392 3Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 1Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 2Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 3Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 4Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 5Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 6Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 202 7
... to Company Oncology Programs to be Presented, SOU...re-FirstCall/ -- Cytokinetics, Incorporated announ...l data will be,presented at the 2007 Annual Meetin...(AACR) to be held from April 14- 18, 2007 in,Los A...oncology,programs at Cytokinetics and will present...
...a.--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline...:ADLR) today announced data from Study 767905/014 ... program for,alvimopan (Entereg/Entrareg(R))., Stu...d (12,month) study, was designed to evaluate the l...mg twice daily in patients taking,opioids for chro...
Other Medicine Technology:Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
(Date:1/8/2009)...dications are available that work, CDC officials s...ws) -- The most common strain of flu this season i... but government health officials said Thursday the...lu season so far has been slow, and that other dru...s health officials adopting a watchful attitude fo...
(Date:1/8/2009)...of sugar sitting on the surface of cancer cells ar...t both treating and stopping the spread of certain... prostate, breast, ovarian and lung, among others....m the Gateway for Cancer Research, an Illinois-bas...ra Franco, M.D., Ph.D., and her co-workers at the ...
(Date:1/8/2009)...quick to condemn hurtful comments, study suggests ...- Many people overestimate how strongly they would... , Sixty-three percent of study participants at...er for an experiment with a white person rather th...acist comments about the black person when he left...
(Date:1/8/2009)...AGO, Jan. 8 Allscripts-M...pts Healthcare Solutions, Inc. (Allscripts or,the...or the three and six,months ended November 30, 20...n/prnh/20061005/ALLSCRIPTSLOGO-b ) , The Co... November 30, 2008,include results from legacy Al...
Breaking Medicine News(10 mins):Health News:Common Flu Strain Resistant to Popular Antiviral Drug 2Health News:Common Flu Strain Resistant to Popular Antiviral Drug 3Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Many Turn Blind Eye to Racism 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13
...allowed the counter sale of the diet drug, orlista... possesses a prescription under the name Xenical. ... in the reduction of six pounds in six months time...x pounds in six months. These like any other diet ...
...nal Institute of Immunology are reported to have i...nderstand how the tuberculosis (TB) bacteria survi...oping newer and more effective medicines to combat...ives across the world annually. The research team ...
...Prime Minister Ariel Sharon have declared that his...ive state. // He is also not expected to regain co...orrhage, and he is still breathing with the help o...is reported to be stable. The Re'ut Rehabilitati...
...been granted fast track designation by the US Food...ived the orphan drug designation // recently for t...ally advanced and metastatic medullary thyroid can... drug in the treatment of medullary thyroid carcin...
Other Medicine News:Health News:Demand For Diet Drugs On The Rise 2
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm).
Key periosteal elevators, blade width 1" (25 mm), total length 7 1/2" (191 mm).
Hoen periosteal elevators, No.3, blade width 3/4" (20 mm), total length 7 1/2" (191 mm).
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm).
Medicine Products: